BIOLASE, INC.Securities Purchase Agreement • November 4th, 2019 • Feinberg Larry N • Dental equipment & supplies
Reference is made to that certain Securities Purchase Agreement (the “Purchase Agreement”), by and among BIOLASE, Inc. (the “Company” or “we”), the Schuler Family Foundation (the “Foundation”), and Oracle Partners, LP, Oracle Institutional Partners, LP and Oracle Ten Fund, LP (collectively with the Foundation, the “Investors”) pursuant to which the Investors purchased in the aggregate 69,565 shares of Series E Preferred Stock, par value $0.001 per share (“Series E Preferred Stock”), at a per share price of $57.50 in a private placement.
